Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(10 sites)
United States
Research Site, Orlando, Florida Research Site, Boston, Massachusetts Research Site, Boston, Massachusetts Research Site, New York, New York Research Site, New York, New York Research Site, Nashville, Tennessee Research Site, Houston, Texas Research Site #2, San Antonio, Texas Research Site, San Antonio, Texas Research Site, Fairfax, Virginia